Cleared Traditional

K160532 - Greiner Holdex

K160532 is an FDA 510(k) clearance for Greiner Holdex, manufactured by Greiner Bio-One Na, Inc.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 251-day FDA review.

K160532 · Greiner Bio-One Na, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2016
Decision
251d
Days
Class 2
Risk

K160532 is an FDA 510(k) clearance for the Greiner Holdex. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Greiner Bio-One Na, Inc. (Monroe, US). The FDA issued a Cleared decision on November 3, 2016 after a review of 251 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Greiner Bio-One Na, Inc. devices

FDA 510(k) Submission Details - K160532

510(k) Number K160532 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 2016
Decision Date November 03, 2016
Days to Decision 251 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
122d slower than avg
Panel avg: 129d · This submission: 251d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 454
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K160532.
Safety Blood Collection Set
K163093 · Jiangsu Shenli Medical Production Co., Ltd. · Mar 2017
meso-relle (AAL34, AAL36, AM30G)
K161255 · Biotekne Srl · Jan 2017
BD Pen Needle
K162516 · Becton, Dickinson and Company · Dec 2016
Advocate Insulin Pen Needles
K160199 · Diabetic Supply of Suncoast, Inc. · Oct 2016
CPL Insulin Pen Needle
K151090 · Cpl Co., Ltd. · Sep 2016
CareSens Pen Needle, Softip Pen Needle
K160575 · Yidobio, Inc. · Sep 2016